Table 3 Comparison of outcome parameters for the two groups
S-PAE (n = 34) | AP-PAE (n = 12) | P-value | |
|---|---|---|---|
Percentage of prostatic infarction a (mean ± SD,%) | 32.2 ± 20.7 | 28.0 ± 11.7 | 0.510 |
PV reduction b (mean ± SD,%) | 26.4 ± 15.4 | 33.0 ± 7.6 | 0.062 |
IPSS reduction b (mean ± SD,%) | 58.1 ± 15.9 | 60.2 ± 16.0 | 0.740 |
PVR reduction b (mean ± SD,%) | 65 ± 42 | 56 ± 50 | 0.638 |
Clinical success ratio b (%) | 91.1 (n = 3) | 91.6 (n = 1) | 0.959 |
Complications c -proportion of pts | 5/34 | 3/12 | 0.423 |